This Fund Sold $8.1 Million in American Public Education as Shares More Than Doubled

Prescott Group sold 177,477 shares of American Public Education in Q1 for an estimated $8.13 million, trimming a position whose quarter-end value fell $6.26 million. The stake still represented 3.85% of 13F AUM, and the stock has risen 122.6% over the past year to $55.91, suggesting the sale was more likely portfolio rebalancing than a bearish fundamental call. The company recently reported 2025 revenue up 3.9% to $648.9 million and net income up 152% to $25.3 million, with first-quarter earnings due May 11.

Analysis

The key signal here is not the sale itself but the fact that a fund is trimming a high-beta winner after a vertical rerating into an earnings event. For an education provider with meaningful policy sensitivity, the forward multiple tends to compress quickly once the market starts pricing in “perfect execution,” so even modest portfolio de-risking can be rational if the stock has already moved faster than fundamentals. That makes the name vulnerable to any first-quarter enrollment or margin miss, because positioning is likely more crowded on the long side than the headline trading activity suggests.

The second-order effect is that this kind of selling often reinforces a feedback loop in momentum-owned small/mid caps: reduced institutional sponsorship can widen the air pocket on any negative catalyst, while strong earnings can still produce sharp upside because underowned longs are forced to chase. The real short-term risk is not deterioration in the business, but a reset in expectations if management guides conservatively on post-peak growth or comments on federal aid, healthcare enrollment, or marketing efficiency. If the May print is merely “good,” the stock can still sell off because the hurdle rate has become much higher after a 120%+ annual move.

Competitively, APEI’s strongest execution may pressure peers that depend on the same nontraditional student cohorts, especially where healthcare program growth is the main incremental driver. But that also means the franchise is increasingly tied to a narrow set of demand vectors, making the durability of current margin expansion more important than top-line growth alone. The market is likely underweight the possibility that recent outperformance has already pulled forward several quarters of good news.

Consensus is treating this as a benign trim, and that is probably right directionally, but the asymmetry is now on the downside into earnings. The best contrarian setup is not outright bearishness on the business; it is betting that the stock has outrun near-term fundamentals and that the next catalyst is more likely to disappoint relative to elevated expectations than to reaccelerate meaningfully from here.

Key Decisions for Investors

• Avoid initiating fresh longs in APEI ahead of the May 11 earnings print; the setup favors post-event entry only if guidance confirms that recent margin gains are sustainable.
• For holders, consider a tactical hedge: buy near-dated APEI puts or a put spread into earnings to protect against an expectations reset from a merely solid quarter.
• Pair trade idea: long stronger cash-generative education/consumer names with less policy beta, short APEI into earnings, targeting a 4-8 week reversion if the print is good-but-not-great.
• If APEI gaps up on earnings, use strength to trim rather than add; the risk/reward after a large one-year run is poor unless management raises full-year guidance materially.
• Monitor enrollment and operating leverage commentary closely; if management signals slower growth in healthcare programs, the stock could de-rate 15-25% quickly as momentum holders exit.